Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy Meeting Abstract
| Authors: | Ocearbhaill, R.; Holmes, J.; Bastos, B.; Fu, S. Q.; Muenzen, R.; Cohen, J.; Cicic, D.; Ali, S. |
| Abstract Title: | Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy |
| Meeting Title: | IGCS 2023 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2023 Nov 5-7 |
| Meeting Location: | Seoul, South Korea |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-11-01 |
| Start Page: | A199 |
| End Page: | A200 |
| Language: | English |
| ACCESSION: | WOS:001262421600476 |
| DOI: | 10.1136/ijgc-2023-IGCS.361 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: EP294/#363 -- Source: Wos |
